Oncology and Hematology

3215

LikeLikedUnlike

Episodes 1-15 of 264

Personalizing Care Within the RCC Treatment Paradigm
CME/CE
Personalizing Care Within the RCC Treatment Paradigm
- Eric Jonasch, MD
  Peer
- Brad McGregor, MD
  Peer
- Ulka Vaishampayan, MBBS
  Peer
1.00 credits
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
- Sandra Swain, MD
  Peer
- Virginia Kaklamani, MD
  Peer
0.50 program credits
Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
- Sandra Swain, MD
  Peer
- Virginia Kaklamani, MD
  Peer
0.50 program credits
Duration of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Duration of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
- Sandra Swain, MD
  Peer
- Virginia Kaklamani, MD
  Peer
0.50 program credits
MinuteCE®
Optimizing Ovarian Function Suppression in Hormone Receptor-Positive Breast Cancer: Best Practices for the Community Clinician
- Sandra Swain, MD
  Peer
- Virginia Kaklamani, MD
  Peer
0.50 credits 4 episodes
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
- Sandra Swain, MD
  Peer
- Virginia Kaklamani, MD
  Peer
0.50 program credits
Reviewing the Latest Bladder Cancer Practice Guidelines
MinuteCE®
Reviewing the Latest Bladder Cancer Practice Guidelines
- Elizabeth R. Plimack, MD, MS, FASCO
  Peer
0.50 program credits
MinuteCE®
Understanding the Expanding Role of Antibody-Drug Conjugates in Bladder Cancer
- Elizabeth R. Plimack, MD, MS, FASCO
  Peer
- Lillibeth Velasco, MSN, RN
  Peer
0.50 credits 3 episodes
Patient Perspectives on Bladder Cancer
MinuteCE®
Patient Perspectives on Bladder Cancer
- Elizabeth R. Plimack, MD, MS, FASCO
  Peer
- Lillibeth Velasco, MSN, RN
  Peer
0.50 program credits
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
MinuteCE®
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
- Elizabeth R. Plimack, MD, MS, FASCO
  Peer
0.50 program credits
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
CME/CE
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
- Javier Cortes, MD, PhD
  Peer
- Hope S. Rugo, MD, FASCO
  Peer
0.50 credits
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
CME/CE
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
- Heather McArthur, MD
  Peer
- Margaret Gatti-Mays, MD, MPH
  Peer
0.25 credits
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
CME/CE
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
0.25 credits
Molecular Profiling for HER2+ Advanced Solid Tumors
CME/CE
Molecular Profiling for HER2+ Advanced Solid Tumors
- Eric Van Cutsem, MD, PhD
  Peer
- David SP Tan, MBBS, PhD, PRCP
  Peer
- James Chih-Hsin Yang, MD, PhD
  Peer
- Kathleen Moore, MD, MS, FASCO
  Peer
1.00 credits
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
CME/CE
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
- Jeffrey V. Matous, MD
  Peer
- Donna Catamero, NP
  Peer
0.25 credits

Oncology and Hematology

Episodes 1-15 of 264

Program Chapters

Segment Chapters

Playlist:

Recommended

Episodes 1-15 of 264

Title

Share on ReachMD

Program Chapters

Segment Chapters

Playlist:

Recommended

Get a Dose of ReachMD in Your Inbox and Practice Smarter Medicine